EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effect of a polygenic risk score in patients with late-onset, early-onset, familial, or hereditary colorectal cancer

Hannah Klinkhammer iD, Isabel Spier, Claudia Perne, Per Hoffmann, Reinhard Büttner, Evelin Schröck, Silke Redler, Arne Jahn, Marcus Franke, Gabriela Möslein, Matthias Kloor, Börge Schmidt und 10 weitere

JNCI Cancer Spectrum · 09.05.2026 · 10 (3)

DOI: 10.1093/jncics/pkag041 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI Cancer Spectrum, online erschienen am 11.04.2026. Verfasst von Hannah Klinkhammer und 21 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Medical Biometry and Statistics, Philipps-University of Marburg, Marburg, Germany. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Genetic Risk Score, Multifactorial Inheritance. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Consortium Familial Intestinal Cancer (GC-FIC), German Cancer Aid (Deutsche Krebshilfe), Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study investigates how a polygenic risk score (PRS) influences colorectal cancer (CRC) risk across clinically and molecularly defined risk groups.

Methods

In total, 1839 European-descendant individuals were stratified according to low (<20%), intermediate (20% to 80%), or high (>80%) PRS, based on 93 CRC-associated single-nucleotide polymorphisms (SNPs), for 4 high-risk groups: (i) Lynch syndrome (LS; with CRC: n = 679, CRC-free carriers: n = 422); (ii) early-onset sporadic CRC (EOS-CRC; n = 518); (iii) positive family history for CRC (F-CRC; n = 220); and, in EOS-CRC and F-CRC patients, (iv) MSI/dMMR CRC (n = 144) vs MSS/pMMR CRC (n = 485). CRC risk was compared with population-based controls (n = 3119) and late-onset sporadic CRC patients from UK Biobank (LOS-CRC; n = 781) using multivariable logistic regression and Cox models.

Results

Polygenic risk score (PRS) was significantly increased in all risk groups compared with population controls. Being in the high PRS category doubled CRC risk in EOS-CRC and F-CRC corresponding to cumulative incidences before 50 and 75 years of 24% and 13%, respectively. Polygenic risk score was significantly higher in EOS-CRC than LOS-CRC. In LS, PRS in non-CRC carriers lay between CRC-LS and population controls. Non-LS individuals with MSI/dMMR tumors showed significantly lower PRS than those with pMMR/MSS tumors, but no difference compared with LS CRC individuals.

Conclusions

Polygenic risk score most strongly influences CRC risk in unexplained EOS- and F-CRC. The effect in LS individuals strongly depends on the penetrance of the altered gene and study design. Nonsignificant trends can partly be explained by the sample size of subgroups. Larger collaborative, prospective studies are needed to validate PRS for personalized CRC risk stratification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsGenetic Risk ScoreMultifactorial InheritanceAdultAgedFemaleHumansMaleMiddle AgedAge of OnsetCase-Control StudiesColorectal Neoplasms, Hereditary NonpolyposisLogistic ModelsMicrosatellite InstabilityPolymorphism, Single NucleotideProportional Hazards Models

Autor:innen und Institutionen

  • Institute for Medical Biometry and Statistics, Philipps-University of Marburg, Marburg, Germany.
  • Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn, Bonn, Germany.
  • Institute of Human Genetics, Medical Faculty, University of Bonn, Bonn, Germany.
  • National Center for Hereditary Tumour Syndromes, University Hospital Bonn, Bonn, Germany.
  • Hereditary Cancer Syndrome Center, ERN GENTURIS, Bonn, Germany.
  • Institute of Pathology, Cologne University Hospital, Cologne, Germany.

ORCID-Profile: Hannah Klinkhammer, Stefan Aretz

Förderung

  • German Consortium Familial Intestinal Cancer (GC-FIC)
  • German Cancer Aid (Deutsche Krebshilfe)
  • Wellcome Trust

Zitieren

APA

Klinkhammer, H., Spier, I., Perne, C., Hoffmann, P., Büttner, R., Schröck, E., Redler, S., Jahn, A., Franke, M., Möslein, G., Kloor, M., Schmidt, B., Vangala, D., Nguyen, H. P., Forstner, A. J., Steinke-Lange, V., Holinski-Feder, E., Hüneburg, R., Maj, C., …, & Aretz, S. (2026). Effect of a polygenic risk score in patients with late-onset, early-onset, familial, or hereditary colorectal cancer. JNCI Cancer Spectrum, 10(3). https://doi.org/10.1093/jncics/pkag041

Vancouver

Klinkhammer H, Spier I, Perne C, Hoffmann P, Büttner R, Schröck E, et al. Effect of a polygenic risk score in patients with late-onset, early-onset, familial, or hereditary colorectal cancer. JNCI Cancer Spectrum. 2026;10(3). doi:10.1093/jncics/pkag041

BibTeX
@article{Klinkhammer2026,
  author = {Klinkhammer, Hannah and Spier, Isabel and Perne, Claudia and Hoffmann, Per and Büttner, Reinhard and Schröck, Evelin and Redler, Silke and Jahn, Arne and Franke, Marcus and Möslein, Gabriela and Kloor, Matthias and Schmidt, Börge and Vangala, Deepak and Nguyen, Huu Phuc and Forstner, Andreas J and Steinke-Lange, Verena and Holinski-Feder, Elke and Hüneburg, Robert and Maj, Carlo and Engel, Christoph and Mayr, Andreas and Aretz, Stefan},
  title = {Effect of a polygenic risk score in patients with late-onset, early-onset, familial, or hereditary colorectal cancer},
  journal = {JNCI Cancer Spectrum},
  year = {2026},
  volume = {10},
  number = {3},
  doi = {10.1093/jncics/pkag041}
}
Kostenlos starten →